Cleared Traditional

K803121 - MENTOR 150 TRANSCUTANEOUS NERVE STIMULA

K803121 is an FDA 510(k) clearance for MENTOR 150 TRANSCUTANEOUS NERVE STIMULA, manufactured by George H. Frisch. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 19-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1980
Decision
19d
Days
Class 2
Risk

K803121 is an FDA 510(k) clearance for the MENTOR 150 TRANSCUTANEOUS NERVE STIMULA. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by George H. Frisch (Mchenry, US). The FDA issued a Cleared decision on December 30, 1980 after a review of 19 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K803121

510(k) Number K803121 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 11, 1980
Decision Date December 30, 1980
Days to Decision 19 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
130d faster than avg
Panel avg: 149d · This submission: 19d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K803121.
TENS-O-MATIC
K811012 · O-Matic, Inc. · Jun 1981
NEUROPAC ULTRA I
K810593 · Medical Devices, Inc. · Mar 1981
MENTOR 402 TRANSCUTANEOUS ELEC. STIMULAT
K803113 · George H. Frisch · Dec 1980
TRANSCUTANEOUS ELECTRIC NERVE STIMULATOR
K802678 · General Medical Industries, Inc. · Dec 1980
LOAD SENTINEL II, TRANS. ELEC. NERVE
K802779 · Powers Medical Systmes · Dec 1980
TENSMATE EMPIMODEL 9980
K802507 · Empi · Dec 1980